AKAN: Akanda Corporation Earnings per share for the last twelve months

Graphic logo of Akanda Corp. (AKAN)

Akanda is actively implementing autonomous AI irrigation systems and robotic packaging. The issuer's financial stability is subject to regulatory risks and price volatility. This rolling annual EPS chart demonstrates fundamental return on capital, where -111.87 reflects the metric's baseline level. The company's revenues are based on the export of medical raw materials from Lesotho to Europe and the creation of cannabidiol-based pharmaceuticals.

AKAN (Akanda) Net earnings per share (EPS TTM) history from 04/28/2023 to 11/12/2026

Summary analytical data breakdowns for Akanda Corp (AKAN)

- current quotes and average value forecast:
Price Chart Akanda|AKAN - Fair Value Consensus
- market capitalization information:
Market Value Akanda Corp.|AKAN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Akanda|AKAN - Book Capitalization|Market Value to Book Value Ratio akandacorp.com|AKAN - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Akanda|AKAN - Long-Term Debt to Capital|Short-Term Debt to Equity Akanda Corporation|AKAN - Company Aggregate Debt|Debts to Book Capitalization Akanda Corp.|AKAN - Company Long-Term Indebtedness|Company Short-Term Debts Akanda|Quick Ratio akandacorp.com
- net income and valuation multiples indicators:
AKAN - Net Profit|Expected Profit Akanda|AKAN - P/E Multiple|Forward P/E Multiple Akanda Corp.|AKAN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akanda Corp.|AKAN - Operating profit before amortization|Earnings per share for the last twelve months Akanda|AKAN - Earnings per share for the last 12 months|Quarterly EPS earnings growth akandacorp.com|AKAN - Earnings growth in current year|Net earnings per share growth forecast for next year Akanda
Fundamental valuation:Akanda (AKAN)
Manufactured products of Akanda Corporation

Akanda operates within an extremely stringent regulatory environment for international medical cannabis. The current trailing twelve-month EPS aggregates net income allocated per share, excluding quarterly anomalies and the impact of issuance. The trend of this metric measures real business efficiency per ownership stake. For a company facing strict export quotas and licensing barriers, such a metric confirms financial stability. The stability of the line serves as an indicator of the price's ability to withstand the pressure of regulatory risks.

Direct competitors

INDV - Earnings per share for the last twelve months|Earnings per share for the trailing year COLL (collegiumpharma.com)|Cronos Group (CRON) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Canopy Growth Corp|HITI (High Tide Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Aurora|Earnings per share for the last twelve months Achieve Life Sciences (ACHV)|Net earnings per share (EPS TTM) Skye Bioscience Inc. (SKYE)|Net earnings per share (EPS TTM) ANEB (Anebulo Pharmaceuticals, Inc.)|Net earnings per share (EPS TTM) InterCure Ltd INCR|NTRB - Earnings per share for the last twelve months|NSRX (Nasus Pharma Ltd) - Earnings per share for the last 12 months|IGC: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months MIRA|FLGC (Flora Growth) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) IMC|Net earnings per share (EPS TTM) ADIL|Net earnings per share (EPS TTM) artelobio.com (ARTL)|Earnings per share for the last twelve months Ensysce Biosciences, Inc. ENSC|Net earnings per share (EPS TTM) Titan Pharmaceuticals Inc. TTNP|Greenlane - Net earnings per share (EPS TTM)|INM - Net earnings per share (EPS TTM)|Enveric (ENVB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months BGXX|Earnings per share for the last twelve months Hempacco Co., Inc.